83 related articles for article (PubMed ID: 2462166)
1. Effect of the intracellular calcium antagonist HA1004 on cerebral blood flow in rats.
Okada T; Shibuya M; Suzuki Y; Ikegaki I; Kageyama N; Asano T; Hidaka H
Neurol Med Chir (Tokyo); 1988 Jul; 28(7):625-30. PubMed ID: 2462166
[No Abstract] [Full Text] [Related]
2. Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
Asano T; Hidaka H
J Pharmacol Exp Ther; 1985 May; 233(2):454-8. PubMed ID: 3999029
[TBL] [Abstract][Full Text] [Related]
3. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
Ono K; Iwatsuki N; Obara S; Hashimoto Y
Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
[No Abstract] [Full Text] [Related]
4. Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats.
Grotta JC; Pettigrew LC; Rosenbaum D; Reid C; Rhoades H; McCandless D
Stroke; 1988 Apr; 19(4):447-54. PubMed ID: 3363573
[TBL] [Abstract][Full Text] [Related]
5. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
Szabo L; Hofmann HP
Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
[TBL] [Abstract][Full Text] [Related]
6. Effects of nifedipine and nicardipine on regional cerebral blood flow distribution in patients with arterial hypertension.
Akopov SE; Simonian NA; Kazarian AV
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):685-92. PubMed ID: 9121225
[TBL] [Abstract][Full Text] [Related]
7. [The influence of cinnarizine and alvityl on cerebral blood flow and high nervous activity in chronic cerebral ischemia model].
Gromova OA; Grishina TR; Sadin AV; Nikonov AA; Nazarenko OA; Zhidomorov NIu; Vatsuro AA; Borzunov MP
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):52-3. PubMed ID: 14870694
[No Abstract] [Full Text] [Related]
8. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
Asano T; Hidaka H
J Pharmacol Exp Ther; 1984 Oct; 231(1):141-5. PubMed ID: 6436469
[TBL] [Abstract][Full Text] [Related]
9. [Calcium channel blockers and cerebral circulation].
Uematsu D; Fukuuchi Y
Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
[No Abstract] [Full Text] [Related]
10. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain.
Asano T; Ikegaki I; Satoh S; Mochizuki D; Hidaka H; Suzuki Y; Shibuya M; Sugita K
Br J Pharmacol; 1991 Aug; 103(4):1935-8. PubMed ID: 1912980
[TBL] [Abstract][Full Text] [Related]
11. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats.
Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M
Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672
[TBL] [Abstract][Full Text] [Related]
12. Effect of the calcium antagonist nimodipine on the delayed hypoperfusion following incomplete ischemia in the rat.
Smith ML; Kågström E; Rosén I; Siesjö BK
J Cereb Blood Flow Metab; 1983 Dec; 3(4):543-6. PubMed ID: 6630325
[TBL] [Abstract][Full Text] [Related]
13. Effect of lidoflazine on cerebral blood flow following twelve minutes total cerebral ischemia.
Dean JM; Hoehner PJ; Rogers MC; Traystman RJ
Stroke; 1984; 15(3):531-5. PubMed ID: 6427983
[TBL] [Abstract][Full Text] [Related]
14. The cerebovasculature: a smooth (muscle) operator?
Low DA
J Physiol; 2013 Oct; 591(20):4959-60. PubMed ID: 24130321
[No Abstract] [Full Text] [Related]
15. Ca2+ antagonist and protection of the brain against ischemia. Effects of nicardipine on free fatty acid liberation in the ischemic brain in rats.
Kidooka M; Matsuda M; Handa J
Surg Neurol; 1987 Dec; 28(6):437-40. PubMed ID: 3686323
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
17. Brain ischemia as a target for Ca2+ entry blockers.
Wauquier A; Ashton D; Clincke GH
Ann N Y Acad Sci; 1988; 522():478-90. PubMed ID: 3288057
[No Abstract] [Full Text] [Related]
18. [Cerebral circulation and calcium antagonists].
Uematsu D; Fukuuchi Y
No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
[No Abstract] [Full Text] [Related]
19. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
Kyoi K; Utsumi S
Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
[No Abstract] [Full Text] [Related]
20. Flow thresholds in brain ischaemia and the effects of drugs.
Symon L
Br J Anaesth; 1985 Jan; 57(1):34-43. PubMed ID: 3881114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
